Fresenius Medical Care AG (FMS)
19.51
+0.12
(+0.62%)
USD |
NYSE |
Apr 19, 12:24
Fresenius Medical Care Free Cash Flow (Quarterly): 498.40M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 498.40M |
| September 30, 2023 | 676.88M |
| June 30, 2023 | 928.78M |
| March 31, 2023 | 0.7561M |
| December 31, 2022 | 441.16M |
| September 30, 2022 | 467.66M |
| June 30, 2022 | 617.17M |
| March 31, 2022 | -3.803M |
| December 31, 2021 | 481.77M |
| September 30, 2021 | 566.95M |
| June 30, 2021 | 857.81M |
| March 31, 2021 | 28.13M |
| December 31, 2020 | 237.79M |
| September 30, 2020 | 748.56M |
| June 30, 2020 | 2.313B |
| March 31, 2020 | 333.37M |
| December 31, 2019 | 493.17M |
| September 30, 2019 | 637.43M |
| June 30, 2019 | 626.22M |
| March 31, 2019 | -142.32M |
| December 31, 2018 | 451.10M |
| September 30, 2018 | 562.14M |
| June 30, 2018 | 500.19M |
| March 31, 2018 | -327.14M |
| December 31, 2017 | 200.02M |
| Date | Value |
|---|---|
| September 30, 2017 | 499.28M |
| June 30, 2017 | 743.11M |
| March 31, 2017 | -29.78M |
| December 31, 2016 | 561.12M |
| September 30, 2016 | 192.93M |
| June 30, 2016 | 424.77M |
| March 31, 2016 | -70.45M |
| December 31, 2015 | 252.33M |
| September 30, 2015 | 346.37M |
| June 30, 2015 | 152.20M |
| March 31, 2015 | 256.39M |
| December 31, 2014 | 361.49M |
| September 30, 2014 | 512.20M |
| June 30, 2014 | 230.10M |
| March 31, 2014 | -87.00M |
| December 31, 2013 | 320.66M |
| September 30, 2013 | 408.12M |
| June 30, 2013 | 335.65M |
| March 31, 2013 | 173.25M |
| December 31, 2012 | 335.12M |
| September 30, 2012 | 326.75M |
| June 30, 2012 | 313.22M |
| March 31, 2012 | 350.64M |
| December 31, 2011 | 337.37M |
| September 30, 2011 | 328.58M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-3.803M
Minimum
Mar 2022
2.313B
Maximum
Jun 2020
576.39M
Average
498.40M
Median
Dec 2023
Free Cash Flow (Quarterly) Benchmarks
| DaVita Inc | 326.23M |
| Biodexa Pharmaceuticals Plc | -- |
| NuCana PLC | 0.3701M |
| Biophytis SA | -- |
| TC BioPharm (Holdings) PLC | -- |